145 results
8-K
EX-10.1
PLSE
Pulse Biosciences Inc
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
by an independent firm immediately prior to a Change of Control (the “Firm”), whose determination will be conclusive and binding upon Executive and the Company
8-K
EX-10.2
PLSE
Pulse Biosciences Inc
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
by a majority of the Company’s “Independent Directors” (as defined under the Nasdaq Listing Rules) or the independent Compensation Committee